1315 closes $300M 1315 Capital II fund

1315 Capital LLC (Philadelphia, Pa.) closed its 1315 Capital II fund on Feb. 12 at over $300 million, exceeding its $250 million target. The fund will invest $10-$30 million per company. The company, which has more than $500 million under management, invests in commercial-stage specialty pharmaceutical, medical technology and healthcare services companies...